Cytokinetics stock price.

A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Historical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of February 19, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide</a>.-- Cytokinetics has an average rating of outperform and price targets ranging from $42.40 to $122, according to analysts polled by Capital IQ. Price: 81.22, Change: -1.52, Percent Change: -1.84 ...Cytokinetics (CYTK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. ... UBS also downgraded the stock to a Hold with a $92.00 price target ...

Cytokinetics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CYTK updated stock price target summary.

Shares of Cytokinetics, ... Stock Market News, Jan. 8, 2024: S&P 500 Rebounds, Boosted by the Magnificent Seven Boeing shares fell, weighing on the Dow industrials; Nvidia climbs.UNATTRACTIVE: Cytokinetics exhibits a price/sales ratio which exceeds the industry average for drugs stocks listed on the NASDAQ. Price / Sales explained. Company News. 2 Biotechs That Could Get Bought Out in 2024. January 3rd, 2024 - Motley Fool.

Cytokinetics to Announce Fourth Quarter Results on February 27, 2024. Globe Newswire • 10 days ago. Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.View live Cytokinetics, Incorporated chart to track its stock's price action. Find market predictions, CYTK financials and market news. ugurhan. Morgan Stanley downgraded its rating of Cytokinetics (NASDAQ:CYTK) to equal weight, but raised its price target, stating it saw the shares approaching full valuation.The investment bank ...MASI Options Chain. Options Chain Tools: Short Interest Tracker. Short Interest Increases. Short Interest Decreases. Unusual Call Volume. Unusual Put Volume. This page (NASDAQ:CYTK) was last updated on 2/23/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.

Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Jan 11, 2024 ... Disaster of the day - Cytokinetics, NASDAQ: CYTK. 306 views · 3 weeks ago ... What Are Stock Market Indicies? (S&P 500, Dow Jones, & NASDAQ ...

Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The last closing price for Cytokinetics was $78.56. Over the last year, Cytokinetics shares have traded in a share price range of $ 25.98 to $ 110.25. Cytokinetics currently has 98,053,647 shares ...The last closing price for Cytokinetics was $78.56. Over the last year, Cytokinetics shares have traded in a share price range of $ 25.98 to $ 110.25. Cytokinetics currently has 98,053,647 shares ...Cytokinetics (CYTK) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Cytokinetics, Inc. Wednesday announced positive results from SEQUOIA-HCM, the pivotal Phase 3 clinical trial of Aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.In the pre-market session, the shares are at $70.02, up 53.69 percent from its previous close of $45.71. The results of SEQUOIA-HCM showed that …

The report was about the company’s stock. In addition, they lowered their price objective on Cytokinetics’ shares, bringing it down from $80.00 to $66.00. Cytokinetics stock has seen its price target cut by Needham & Company LLC, announced in a report released on Friday, December 23rd. The new price target is $58.00, down …Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by UBS on January 24, 2024. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...The Cytokinetics stock forecast for tomorrow is $ 76.52, which would represent a 0.03% gain compared to the current price. In the next week, the price of CYTK is expected to decrease by -1.11% and hit $ 75.65. As far as the long-term Cytokinetics stock forecast is concerned, here’s what our ...

CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks.

According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...-144.87(-0.92%) Russell 2000 -28.60(-1.41%) -0.92(-1.16%) Gold +11.60(+0.57%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 76.89 0.00... CYTK) stock’s latest price update. Cytokinetics Inc (NASDAQ: CYTK) has seen a decline in its stock price by -1.19 in relation to its previous close of 76.50. However, the company has experienced a -1.19% decline in its stock price over the last five trading sessions. GlobeNewsWireCYTK stock forecast for 2023 – 2027. Last updated: November 14, 2023. Cytokinetics, Incorporated. 32.44 D 2.40% (0.76) Are you interested in Cytokinetics, Incorporated stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CYTK stock price in 2022-2027. Is CYTK a good long term …Cytokinetics (CYTK) Stock Price Performance. Cytokinetics (CYTK) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Get the latest Cytokinetics, Incorporated (CYTK) stock news and headlines to help you in your trading and investing decisions. On average, Wall Street analysts predict. that Cytokinetics's share price could reach $83.36 by Jan 24, 2025. The average Cytokinetics stock price prediction forecasts a potential upside of 8.42% from the current CYTK share price of $76.89.Cytokinetics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.

This indicates that the analyst believes the stock is currently undervalued and has the potential for price appreciation, with a specific target of $66.00. When looking at the average twelve-month price prediction for Cytokinetics, it stands at $58.64. However, there is also a high price target of $80.00 and a low price target of $42.00.

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Cytokinetics (CYTK – Research Report) yesterday and set a price target of $122.00. Mayank Mamtani’s Buy rating is based on ...

Market capitalization of Cytokinetics (CYTK). Market cap: $7.65 Billion. As of ... Stock prices are delayed, the delay can range from a few minutes to several ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Dec 27, 2023 · However, the average price target of $61.07 is “outdated” due to the dramatic pop today. JPM Securities’ Jason Butler anticipates CYTK hitting $110 per share, translating to roughly 36% ... View real-time Cytokinetics Inc (CYTK) share prices and assess historical data, charts, technical analysis, performance reports and NASDAQ CYTK share chat forum. ... Use the dropdown to select a relevant stock exchange for the current NASDAQ CYTK share price (ISIN: US23282W6057) to enhance your trading decisions with our free resources. Day's ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...57,973.31 -165.23(-0.28%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Add to watchlist 81.87 +0.62 (+0.76%) At close: …Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis. Salim Syed, an analyst from Mizuho Securities, maintained the Buy rating on Cytokinetics (CYTK – Research Report). The associated price target is $103.00. Salim Syed has given Cytokinetics a Buy ...

Company profile for Cytokinetics, Incorporated (CYTK) with a description, list of executives, contact details and other key facts. ... Stock Analysis Pro. Watchlist. Collapse. Cytokinetics, Incorporated (CYTK) NASDAQ: CYTK · IEX Real-Time Price · USD. Add to Watchlist 76.89-1.67 (-2.13%) At close: Feb 16, 2024, 4:00 PM. 77.10 +0.21 …UNATTRACTIVE: Cytokinetics exhibits a price/sales ratio which exceeds the industry average for drugs stocks listed on the NASDAQ. Price / Sales explained. Company News. 2 Biotechs That Could Get Bought Out in 2024. January 3rd, 2024 - Motley Fool.Historical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of February 19, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide</a>.Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Instagram:https://instagram. carolina harbor photosgoodness of god lyricsthe house netflixvintage lawn jockey for sale Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert I. Blum sold 12,500 shares of the company's stock in a transaction on Friday, January 19th.The stock was sold at an average price of $81.42, for a total value of $1,017,750.00. Following the sale, the chief executive officer now directly owns 441,797 shares in the … maroon 5 animals lyricssong car race Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …Dec 28, 2023 · The biotech company showed 0% earnings growth in its most recent report. Sales rose -85%. Cytokinetics stock earns the No. 149 rank among its peers in the Medical-Biomed/Biotech industry group. lions vs broncos Cytokinetics will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Cytokinetics’ election. The initial conversion rate is 19.5783 shares of common stock per $1,000 principal amount of notes, which represents an initial conversion price …If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Historical stock closing prices for Cytokinetics, Incorporated (CYTK). See each day's opening price, high, low, close, volume, and change %.